Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-0.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-40.12%
202424.35%
2023171.79%
2022-35.49%
202110.08%
202070.35%
201958.94%
20181145.12%
2017256.37%
20160.00%